JANCT: Japanese National Computed Tomographic (CT) Colonography Trial

Sponsor
Japanese CT Colonography Society (Other)
Overall Status
Completed
CT.gov ID
NCT00997802
Collaborator
(none)
1,257
12
1
87
104.8
1.2

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the sensitivity of computed tomographic colonography (CTC) in detecting colorectal polyps and cancers in 1,500 subjects at increased risk of colorectal cancer (CRC), using optical colonoscopy as the reference standard.

Condition or Disease Intervention/Treatment Phase
  • Device: CT colonography and optical colonoscopy
N/A

Detailed Description

The investigators will evaluate the sensitivity of CTC in detecting colorectal polyps and cancers (at least 6 mm in diameter) in 1,500 subjects at increased risk of colorectal cancer (CRC), using optical colonoscopy as the reference standard. The primary endpoint will be sensitivity in the detection of colorectal polyps and cancers that are at least 6 mm in diameter. The secondary endpoints will include specificity and predictive values in the detection of colorectal polyps and cancers.

This clinical study will also evaluate the differences of the detection accuracies between human readings with and without computer-aided detection (CAD) that automatically detects colonic lesions in CTC images and presents the detected lesions to the readers. This clinical study will also compare performance between radiologists and gastroenterologists in detecting colorectal lesions in CTC images.

All the CTC images and their interpretations, optical colonoscopy reports and images, and pathology reports of resected colorectal lesion will be prospectively collected from 12 Japanese hospitals participating in the trial. All patients' information will be completely anonymized at each site before any analysis of the data takes place.

Study Design

Study Type:
Interventional
Actual Enrollment :
1257 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Evaluation of Accuracy of Computed Tomographic Colonography (CTC) in the Diagnosis of Colorectal Tumors by Gastroenterologists and Radiologists With Computer-aided Detection (CAD): A Multicenter Study
Study Start Date :
Oct 1, 2009
Actual Primary Completion Date :
Dec 11, 2015
Actual Study Completion Date :
Jan 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Other: CT colonography and optical colonoscopy

Device: CT colonography and optical colonoscopy
All patients will undergo CT colonography and optical colonoscopy.

Outcome Measures

Primary Outcome Measures

  1. sensitivity in the detection of colorectal polyps and cancers in CTC [1.5 years]

Secondary Outcome Measures

  1. specificity and predictive values in the detection of colorectal polyps and cancers in CTC. [1.5 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Outpatients who are eligible for optical colonoscopy.

  • Aged 20 years or older.

  • Major functions of organs of the subjects are in a good condition.

  • Signed informed consent forms are obtained from the patients.

Exclusion Criteria:
  • Known colorectal polyps or cancers at any site at the time of enrollment.

  • Patients with inflammatory bowel disease.

  • Fulfillment of clinical criteria for diagnosis of FAP or HNPCC (Amsterdam criteria).

  • Serious medical conditions that may increase the risk of optical colonoscopy or are so severe that screening would have no benefit.

  • Previous colorectal surgery.

  • Gastric or intestinal stenosis, abdominal adhesions, bowel obstruction or perforation, toxic megacolon.

  • Evidence of an increased risk in carrying out bowel preparation or CTC exams.

  • Possibility of pregnancy.

  • Optical colonoscopy or barium enema carried out within the last 3 years.

  • Patients with psychological conditions that contraindicate colonoscopy or that make them irrelevant to participate in the trial.

  • Iodine hypersensitivity.

  • Severe thyroid disease.

  • Claustrophobia.

  • Severe deafness.

  • Subjects whose eligibility for this clinical trial is not appropriate by other reasons.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Japanese CTC Society, 3D imaging Laboratory, Massachusetts General Hospital Boston Massachusetts United States 02114
2 Otarukyokai Hospital Otaru Hokkaido Japan 047-8510
3 Tonan Hospital Sapporo Hokkaido Japan 060-0001
4 Hokkaido Social Insurance Hospital Sapporo Hokkaido Japan 062-8618
5 Hokkaido Gastroenterology Hospital Sapporo Hokkaido Japan 065-0041
6 Kanazawa University Hospital Kanazawa Ishikawa Japan 920-8641
7 Showa University Northern Yokohama Hospital Yokohama Kanagawa Japan 224-8503
8 Kamigoto Hospital Kamigoto Nagasaki Japan 857-4404
9 Kawasaki Medical School Kurashiki Okayama Japan 701-0192
10 Hamamatsu South Hospital Hamamatsu Shizuoka Japan 430-0846
11 Jichi Medical University Hospital Shimono Tochigi Japan 329-0498
12 Tokyo Women's Medical University Medical Center East Arakawa-ku Tokyo Japan 116-8567

Sponsors and Collaborators

  • Japanese CT Colonography Society

Investigators

  • Study Director: Koichi Nagata, MD, PhD, Japanese CTC Society

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Hiroyuki Yoshida, 3D Imaging Laboratory, Massachusetts General Hospital, Japanese CT Colonography Society
ClinicalTrials.gov Identifier:
NCT00997802
Other Study ID Numbers:
  • UMIN000002097
First Posted:
Oct 19, 2009
Last Update Posted:
Mar 17, 2017
Last Verified:
Mar 1, 2017
Keywords provided by Hiroyuki Yoshida, 3D Imaging Laboratory, Massachusetts General Hospital, Japanese CT Colonography Society
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 17, 2017